|
As a forum for the exchange of information in the field of cancer
immunology, Cancer Immunity
provides rapid publication of original research, retrospectives,
methods and opinion pieces.
Cancer
Immunity publishes papers in the following categories:
-
Articles describing the results of original laboratory
and clinical research.
-
Reviews providing critical and balanced views of
specific topics.
-
Commentaries discussing papers recently published
in Cancer Immunity
or other journals. In addition, Cancer
Immunity welcomes Commentaries dealing with
any matter of importance to tumor immunology and immunotherapy.
-
Reflections presenting a personal perspective on
the origins and history of the field of tumor immunology
by leaders in the field. Reflections are invited by the
editors.
Reader's comments on papers are compiled and linked to the original
publication to further scientific discussion. Please use the "Comment(s)"
feature in the original publication to submit such comments.
Please read all guidelines carefully and follow them strictly
to ensure that the processing and publication of your manuscript
is as efficient as possible. For further guidance, please contact
the Editorial Office.
Editorial
Policies
It is a condition of publication that manuscripts submitted to
this Journal have not been published and will not be simultaneously
submitted or published elsewhere. Reporting of findings to the
mass media may also preclude a paper from publication. Exception
will be made for abstracts and oral presentations from scientific
meetings published as part of the meeting's proceedings. If previously
published tables, illustrations or more than 200 words of text
are to be included, the copyright holder's written permission
must be obtained for online use and must accompany the accepted
manuscript. Submission of manuscripts describing unique research
materials (e.g. chemical and biological reagents, databases) implies
that these will be made available for noncommercial purposes to
all qualified investigators upon request. GenBank/EMBL/DDBJ
database accession numbers for new sequence data must be supplied
for publication.
Authors
will retain the copyright to any material they publish in the
Journal. While retaining copyright, authors agree to acknowledge
Cancer Immunity as
the original place of publication in all future publications.
Any
relationships, financial or otherwise, that might lead to a conflict
of interest must be disclosed to the Editorial Office at the time
of submission.
No
liability is accepted for loss or damage of materials submitted.
Authors should keep a copy of all files or of the manuscript.
Unless specifically requested, manuscripts will NOT be returned.
Manuscript
Submission
Cancer Immunity
accepts manuscripts contributed directly by Members of the Academy of Cancer Immunology
and welcomes manuscripts by non-Members.
Manuscripts
contributed by Members of the Academy of Cancer Immunology
are accepted upon submission. It is the Member's responsibility
to have the manuscript reviewed by two colleagues outside his
or her institution before it is submitted. The Member should provide
the names of the reviewers at the time of submission.
Non-Members
of the Academy may submit manuscripts to a Member
of the Academy OR to the Editorial Office.
Manuscripts not submitted directly to a Member will be assigned
to one by the Editorial Office. Authors may include suggestions
of Members whose expertise would make them suitable editors. Whether
a manuscript is submitted to a Member, or assigned to a Member
by the Editorial Office, the Member will be responsible for having
the manuscript reviewed by two individuals knowledgeable in the
area. Reviewers may or may not be Academy Members.
Manuscripts
will be evaluated based on the contribution of original material
that is likely to be of interest to readers involved in cancer
immunology. Editorial comments will be communicated to the contributor
at the discretion of the Editorial Board.
Articles
contributed directly by Members of the Academy are distinguished
in the Journal as "Contributed by". Articles by non-Member authors
are distinguished in the Journal as "Communicated by" [the editor
responsible for the review process].
A
non-Member manuscript that is rejected by the Journal may not
be resubmitted by a Member.
Preparation
Manuscripts may be submitted electronically OR in hard-copy format.
All submissions must be accompanied by copies of any papers cited
in the text that are accepted but not yet published, any manuscripts
submitted but not yet accepted, and any related material in press
or submitted elsewhere (by all co-authors). Please indicate if
it is a resubmission and, if so, the name of the member of the
Editorial Board to whom it was originally submitted (if not the
Editorial Office).
Electronic Submission. Manuscripts should be submitted
as a single text file containing the text and table and figure
legends. Text files in RTF (rich text format) format are preferred.
Other standard word processing file formats will also be accepted.
Each table and figure must be submitted as a separate file. Tables
should be submitted in standard word processing file formats (NOT
RTF) or as images. All figures should be in TIFF format
and have a minimum resolution of 600 pixels/inch. Please
ensure that black and white figures and color figures are in Grayscale
and RGB modes respectively. Figures or tables in different formats
must be supplied as high-quality prints. Please provide the corresponding
author's name, the file names, the operating system (Mac or PC),
as well as the compression and word processing applications used.
All electronically submitted files are to be scanned by the authors
for viruses with appropriate current software immediately prior
to submission, and are submitted in good faith that the files
are free of viruses. If there is any future concern by the authors
regarding possible virus presence in previously submitted material,
the Editorial Office is to be notified promptly. Manuscripts should
be sent either as e-mail attachments or on disc. PC- or Mac-formatted
3.5" and Zip disks and CDs are acceptable. Please note that
disks will not be returned. If files total more than 1 Mb, they
should be placed on a FTP server to be accessed by the Editorial
Office.
Hard Copy Submission. Please submit three (3) copies
of Articles and one (1) copy of Reviews, Commentaries
and Reflections. A complete set of figures for each copy
is required (laser prints on glossy or normal clean white laser
paper are acceptable). Lightly mark each figure or table on the
back with the name of the corresponding author, the figure or
table number, and an indication of the top for figures. Figures
and tables should not be stapled or clipped to the manuscript.
Style
and Organization
Language
Manuscripts are to be written in clear and concise English. Spelling
should conform to either English or American usage and should
be consistent throughout the paper (e.g. tumour, leukaemia, centre
or tumor, leukemia, center).
Length
While there are no specific limitations regarding the length of
the manuscript or the number of figures and tables, authors are
strongly encouraged to be succinct.
Units
The International System of Units
(SI) (http://physics.nist.gov/Pubs/SP811/contents.html) should
be used throughout the manuscript and URLs should conform to the
standard format (e.g. http://www.ebi.ac.uk/).
Superscripts, Subscripts, Symbols
To facilitate the processing of the manuscript for publication,
authors are requested to format superscripts and subscripts using
the Font SUPERSCRIPT and SUBSCRIPT options and symbols using the
SYMBOL Font. The use of symbols in the text is restricted to:
- Greek
characters
- mathematical
symbols, including ± , < , >
- the
symbols * , % , ® , TM
, © , @ , ° and
- 'single'
and "double" quotation marks.
Sections
All manuscripts submitted MUST have a Title page. Articles
and Reviews MUST have an Abstract.
Section
and subsection headings should be on separate lines and in bold.
Title Page
The publication type (Article, Review, Commentary or Reflection)
should be followed by the title of the manuscript, the full
names of the authors, their affiliations and mailing addresses,
as well as the complete mailing address, telephone number, fax
number and e-mail address of the corresponding author. Superscript
numbers should be used to designate institutional affiliations
and a superscript asterisk (*) used to indicate joint first
authorship. The title of the manuscript should be short, specific
and informative. Please do NOT provide a running title or list
of keywords. Keywords from the Medical Subject Headings from
Index Medicus will be assigned by the Editorial Office. Unless
other instructions are provided in this section, all contact
with the corresponding author, including immediate notification
of receipt of the manuscript, will be by e-mail.
Abstract
Summarize for a broad scientific audience. The Abstract should
consist of a single paragraph not exceeding 250 words (abstracts
are truncated at 250 words by PubMed). Do NOT cite references.
Articles
should also contain the following sections organized in the order
shown. Reviews, Commentaries and Reflections
need only include relevant sections.
Introduction
Assume that the reader is knowledgeable in the field.
Results
Present results in logical sequence in the text, tables, and
illustrations. Data should be presented once, either in tables
or figures, but not both. Emphasize or summarize only important
observations.
Discussion
Emphasize the new and important aspects of the study and the
conclusions that follow from them. Relate the observations to
other relevant studies and discuss the implications of the findings
and their limitations.
Abbreviations
Refer to the standard abbreviations
used without definition in the Journal and list nonstandard
abbreviations used five or more times in the text. Define these
where first mentioned in the text and do not use them in the
title of the manuscript.
Acknowledgements
List any individuals who have contributed to the manuscript,
along with sources of funding and material.
References
Please restrict references to published work and to papers in
press closely related to the presented work. These should be
cited sequentially in the text, enclosed in parentheses, e.g.
(1, 2, 3). Cite personal communications, unpublished results,
manuscripts submitted or in preparation and Internet/Web sites
in the References section. List references in numerical order
corresponding to the order of citation in the text. References
should follow the Vancouver format (http://www.icmje.org/index.html).
All authors should be listed for each reference. Standard
MEDLINE abbreviations for the names of journals should be used
and can be found at the National Center for Biotechnology Information
Web site (http://www.ncbi.nlm.nih.gov:80/entrez/jrbrowser.cgi).
Identify abstracts and letters as such. Provide the first and
last page numbers for each reference. The PubMed ID (PMID) for
references to published articles must be included in the final
version to enable direct linking of references to PubMed. To
find the PubMed ID for individual references, you can use the
NCBI Single Citation Matcher (entering the date of publication
and the name of the first or last author usually suffices to
locate the reference):
http://www.ncbi.nlm.nih.gov:80/entrez/query/static/citmatch.html.
To find the PubMed ID for a series of references, use the NCBI
Batch Citation Matcher (refer to the instructions): http://www.ncbi.nlm.nih.gov:80/entrez/getids.cgi.
Examples of references are:
Journal
article
1. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De
Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an
antigen recognized by cytolytic T lymphocytes on a human melanoma.
Science 1991; 254: 1643-7. (PMID: 1840703)
Journal
article, in press
2. Binder RJ, Karimedini D, Srivastava PK. Adjuvanticity of
alpha2-macroglobulin, an independent ligand for the
heat shock protein receptor CD91. J Immunol. In press
2001.
Complete
book
3. Janeway CA Jr, Travers P. Immunology: the immune system in
health and disease. 2nd ed. New York: Garland Publishing; 1996.
Chapter
in book
4. Chen YT, Scanlan MJ, Obata Y, Old LJ. Identification
of human tumor antigens by serological expression cloning. In:
Rosenberg SA, editor. Principles and practice of the biologic
therapy of cancer. 3rd ed. Philadelphia (PA): Lippincott Williams
& Wilkins; 2000. p. 557-70.
Abstract
5. Greenberg PD, Yee C, Topp M, Bonini C, Cheng L, Cooper L,
Liao M, Ohlen C, Houston Warren E, Gavin M, Riddell SR. T-cell
therapy for malignant diseases - validating antigenic targets
and making T cells work [abstract]. Cancer Vaccines
2000; 8: 18.
Letter
to the Editor
6. Schultz H, Krenn V, Tony HP. Oligoarthritis mediated by tumor-specific
T lymphocytes in renal-cell carcinoma [letter]. N Engl J
Med 1999; 341: 290-1. (PMID: 10419392)
Materials and Methods
A statement that all experiments were performed in compliance
with institutional guidelines and relevant laws and identifying
the committee(s) that have approved the experiments must be
included for papers reporting experiments involving live animals
or human subjects. Papers presenting research involving human
subjects must also include a statement that informed consent
was obtained from each subject or subject's guardian. Names
and addresses of suppliers of uncommon reagents or instruments
should be provided. Refer to published methods wherever possible,
and clearly describe new or substantially modified methods.
Table and Figure Legends
List legends in the order of appearance. Provide a brief descriptive
title in bold and a detailed legend. Explain any abbreviations
in tables using footnotes indicated by lower case letters (e.g.
a, b, c). ALL symbols used in figures, other than accepted symbols,
must be described using words in the legend or defined in an
inset within the figure.
Tables and Figures
Number tables and figures consecutively, but separately, with
Arabic numerals. Tables and figures are to be submitted separately
from the text at the desired printed size, with clearly legible
numbers, letters, and symbols. Each table or figure should be
no larger than 20.3 cm (8 inches) wide and 25.4 cm (10 inches)
high. The use of color is encouraged where it improves clarity,
e.g. for comparative sequence data. Avoid wide variation in type
size within a single table or figure. Units of measure should
be included in parentheses in column headings or axes; units should
not change within a column or axis. Please ensure that figures
do NOT have a frame. Composite figures should be labeled A, B,
C and submitted as one figure. Any lettering or text should be
in proportion with the rest of the figure. Use boldface type for
axis labels and for labels in composite figures. For graphs, use
powers of 10 for scales with large or small numbers. Figures and
tables will NOT be redrawn or relabeled.
Supplemental Data
Supplemental Data may take the form of supporting figures, tables,
datasets, databases, and videos. Please contact the Editorial Office
to discuss the submission and format of such data.
Accepted
Manuscripts
Upon acceptance for publication, the corresponding author must
submit the text of the final version electronically to
the Editorial Office. While figures
and tables may be supplied in electronic form, all figures and
complex tables must also be supplied as high-quality, glossy prints.
These will be scanned if necessary. Photocopies are NOT acceptable.
The manuscript, figures and tables should include any modifications
requested by the reviewers. No charges are levied for handling
of the manuscript.
Written
permission to cite accepted or submitted manuscripts along with
verification that they have been accepted for publication must
be provided by the authors. Written permission and confirmation
of accuracy from the source of any personal communications cited
in the paper must also be provided. Statements that the manuscript
has been read and approved by all the authors, that each author
believes that the manuscript represents honest work, and that
the contents of the manuscript have not been previously published,
must accompany the manuscript. Sequence and structural data must
be deposited with the appropriate data bank prior to publication,
and the corresponding entries must be provided for inclusion in
the published manuscript.
The
corresponding author is responsible for communicating with the
other authors about revisions and final approval of the proofs.
Unless otherwise requested, copyright to the material published
in the Journal will be attributed to the corresponding author.
|
